Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elisabeth Gray"'
Autor:
Wenqiang Liu, Michael Nguyen-Truong, Kristen LeBar, Kevin M. Labus, Elisabeth Gray, Matt Ahern, Sunder Neelakantan, Reza Avazmohammadi, Kirk C. McGilvray, Christian M. Puttlitz, Zhijie Wang
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Cardiac biomechanics play a significant role in the progression of structural heart diseases (SHDs). SHDs alter baseline myocardial biomechanics leading to single or bi-ventricular dysfunction. But therapies for left ventricle (LV) failure patients d
Externí odkaz:
https://doaj.org/article/a5c905872c2b48708394cd93cd01c3fa
Autor:
Derwich, Daphne Elisabeth Gray, Carla Samaan, Kyriakos Oikonomou, Tatjana Gruber-Rouh, Thomas Schmitz-Rixen, Wojciech
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7113
In the past two decades, endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) has become the first line treatment for infrarenal AAA repair in many countries. While short-term results are good, concerns have been raised about long-ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::18d11406f439ca96862f0e8c416e0968
Autor:
Daphne Elisabeth, Gray, Carla, Samaan, Kyriakos, Oikonomou, Tatjana, Gruber-Rouh, Thomas, Schmitz-Rixen, Wojciech, Derwich
Publikováno v:
Journal of clinical medicine. 11(23)
In the past two decades, endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) has become the first line treatment for infrarenal AAA repair in many countries. While short-term results are good, concerns have been raised about long-ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67547b196845a2285a18ab61a8f14b71
https://pubmed.ncbi.nlm.nih.gov/36498686
https://pubmed.ncbi.nlm.nih.gov/36498686
Autor:
Alberto Sanchez-Fueyo, Elisabeth Gray, Tiong Yeng Lim, Elisavet Kodela, Marc Martinez-Llordella, Michael A. Heneghan
Publikováno v:
Lim, T Y, Martinez-Llordella, M, Kodela, E, Gray, E, Heneghan, M A & Sanchez-Fueyo, A 2018, ' Low Dose Interleukin-2 for Refractory Autoimmune Hepatitis ', Hepatology, vol. 68, no. 4, pp. 1649-1652 . https://doi.org/10.1002/hep.30059
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6611020c26dfee90134c2c6fd71c58b
https://doi.org/10.1002/hep.30059
https://doi.org/10.1002/hep.30059
Autor:
Arun Krishna, Istvan M. Majer, Gijs van de Wetering, Anuja Roy, Elisabeth Gray, Zoltan Polanyi
Publikováno v:
Applied health economics and health policy. 15(1)
In the UK, the standard of care for patients with multiple myeloma who received ≥2 prior treatments is lenalidomide plus dexamethasone (LEN + DEX) and pomalidomide plus DEX (POM + DEX) (in Wales only). Recently, panobinostat plus bortezomib and DEX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f932574449f70dff22575a6c632fc2
https://pubmed.ncbi.nlm.nih.gov/27550239
https://pubmed.ncbi.nlm.nih.gov/27550239
Autor:
Fowler, Elisabeth Gray
Publikováno v:
Connecticut Review; Fall2004, Vol. 26 Issue 2, p177-181, 5p